Research
Metabolic adaptation
GLP-1RAs may raise safety concerns related to weight loss and altered glucose regulation in ALS.
Monitoring for weight loss and glucose regulation is essential when considering GLP-1RAs for ALS.
StrongQualifiesmedium confidence
raising important safety concerns, particularly related to weight loss, lean mass reduction, and altered glucose regulation.
Why this rating
Based on the review of safety concerns mentioned in the abstract.
Source
Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of GLP-1 receptor agonists
Mohamed Mohsen Helal et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2026
reviewCited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →